With its novel mechanism of action and molecular design, PROTAC technology is able to overcome numerous problems of traditional small molecule inhibitors, such as high dose, side effects, drug resistance, and more. Viva's team is able to design and synthesize many different types of PROTAC molecules according to customer needs.
Available E3 ligase ligand molecule types:
Available PROTAC Linker molecule types:
SMC PROTAC chemical synthesis case: